Adaptimmune Therapeutics plc
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2015 | — | -249.6% | -223.5% |
| FY2016 | — | -512.7% | -504.1% |
| FY2017 | — | -213.2% | -185.4% |
| FY2018 | — | -138.4% | -160.5% |
| FY2019 | — | -12,457.2% | -12,225.0% |
| FY2020 | — | -3,370.5% | -3,286.8% |
| FY2021 | — | -2,638.6% | -2,571.0% |
| FY2022 | — | -604.0% | -609.5% |
| FY2023 | — | -231.8% | -188.9% |
| FY2024 | 100.0% | -38.6% | -39.8% |